| Emerging roles of lymphatic endothelium in regulating adaptive immunity CM Card, SY Shann, MA Swartz The Journal of clinical investigation 124 (3), 943-952, 2014 | 252 | 2014 |
| Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4+ CD25+ FOXP3+ regulatory T cells CM Card, PJ McLaren, C Wachihi, J Kimani, FA Plummer, KR Fowke Journal of Infectious Diseases 199 (9), 1318-1322, 2009 | 218 | 2009 |
| The role of regulatory T cells in chronic and acute viral infections Y Keynan, CM Card, PJ McLaren, MR Dawood, K Kasper, KR Fowke Clinical infectious diseases 46 (7), 1046, 2008 | 124 | 2008 |
| Immune quiescence: a model of protection against HIV infection CM Card, TB Ball, KR Fowke Retrovirology 10, 1-8, 2013 | 94 | 2013 |
| Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination A Ssemaganda, HM Nguyen, F Nuhu, N Jahan, CM Card, S Kiazyk, ... Nature communications 13 (1), 3357, 2022 | 51 | 2022 |
| HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential CM Card, Y Keynan, J Lajoie, CP Bell, M Dawood, M Becker, K Kasper, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (5), 427-437, 2012 | 43 | 2012 |
| Reduced Cellular Susceptibility to In Vitro HIV Infection Is Associated with CD4+ T Cell Quiescence CM Card, WJ Rutherford, S Ramdahin, X Yao, M Kimani, C Wachihi, ... Public Library of Science 7 (9), e45911, 2012 | 42 | 2012 |
| Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis JJ Schellenberg, CM Card, TB Ball, JN Mungai, E Irungu, J Kimani, ... Aids 26 (3), 387-393, 2012 | 34 | 2012 |
| HIV vaccine efficacy trials: A brief history, and options for going forward. LR McKinnon, CM Card AIDS reviews 12 (4), 209-217, 2010 | 22 | 2010 |
| Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains Y Keynan, CM Card, BT Ball, Y Li, FA Plummer, KR Fowke Clinical microbiology and infection 16 (8), 1179-1186, 2010 | 19 | 2010 |
| Endothelial Cells Promote Productive HIV Infection of Resting CD4+ T Cells by an Integrin-Mediated Cell Adhesion-Dependent Mechanism CM Card, B Abrenica, LR McKinnon, TB Ball, RC Su AIDS Research and Human Retroviruses 38 (2), 111-126, 2022 | 6 | 2022 |
| Expansion of tissue-resident CD8+ T cells and CD4+ Th17 cells in the nasal mucosa following mRNA COVID-19 vaccination A Ssemaganda, HM Nguyen, F Nuhu, N Jahan, CM Card, S Kiazyk, ... BioRxiv, 2021.05. 07.442971, 2021 | 6 | 2021 |
| The role of G protein gene GNB3 C825TPolymorphism in HIV-1 acquisition, progression and immune activation J Juno, J Tuff, R Choi, C Card, J Kimani, C Wachihi, S Koesters-Kiazyk, ... Retrovirology 9, 1-12, 2012 | 6 | 2012 |
| Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study CA Hitchon, C Mesa, CN Bernstein, RA Marrie, C Card, SF O’Brien, J Kim BMJ open 13 (5), e071397, 2023 | 4 | 2023 |
| Adjuvant-free immunization with infective filarial larvae as lymphatic homing antigen carriers C Card, DS Wilson, S Hirosue, M Rincon-Restrepo, A de Titta, E Güç, ... Scientific reports 10 (1), 1055, 2020 | 1 | 2020 |
| The Immune System and Resisting HIV Infection KR Fowke, CM Card, R Kaul Models of Protection Against HIV/SIV, 211-229, 2012 | 1 | 2012 |
| COVID-19 Infection in People with Immune Mediated Inflammatory Diseases Who Received SARSCo-V2 Vaccines T Shcholok, CN Bernstein, C Card, RA Marrie, C Mesa, J Kim, C Hitchon ARTHRITIS & RHEUMATOLOGY 75, 265-267, 2023 | | 2023 |
| Safety and Immunogenicity of Mixed COVID19 Vaccine Regimens in Immune-mediated Inflammatory Diseases: An Observational Cohort C Hitchon, C Mesa, CN Bernstein, C Card, RA Marrie, S O'Brien, J Kim ARTHRITIS & RHEUMATOLOGY 74, 1429-1431, 2022 | | 2022 |
| Expansion of cytotoxic tissue-resident CD8 T cells and CCR6 CD161 CD4 T cells in the nasal mucosa following mRNA COVID-19 vaccination A Ssemaganda, HM Nguyen, F Nuhu, N Jahan, CM Card, S Kiazyk, ... | | |
Terry Blake BallChief National Laboratory for HIV Immunology, Public Health Agency of CanadaПодтвержден адрес электронной почты в домене cc.umanitoba.ca
